Muyu Situ
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muyu Situ has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Ali Francisco Citalan-Madrid
Department of Pathology (A.V.A., A.F.C.-M., S.M.S.), University of Michigan Medical School, Ann Arbor
1 shared publication- Anuska V. Andjelkovic
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
1 shared publication Jianming Xiang
Department of Neurosurgery (A.V.A., J.X., R.F.K.), University of Michigan Medical School, Ann Arbor
1 shared publication- Richard F. Keep
Department of Neurosurgery, University of Michigan, Ann Arbor, MI 48109, USA
1 shared publication - Svetlana M. Stamatovic
Department of Pathology (A.V.A., A.F.C.-M., S.M.S.), University of Michigan Medical School, Ann Arbor
1 shared publication
Latest Publications
- Top Cited Papers
- 1 March 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (3) , 661-672
Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments
Cerebral endothelial cells and their linking tight junctions form a unique, dynamic and multi-functional interface, the blood-brain barrier (BBB). The endothelium is regulated by perivascular cells and components forming the neurovascular unit. This review examines BBB and neurovascular unit changes in normal aging and in neurodegenerative disorders, particularly focusing on Alzheimer disease, cerebral amyloid angiopathy and vascular dementia. Increasing evidence indicates BBB dysfunction contributes to neurodegeneration. Mechanisms underlying BBB dysfunction are outlined (endothelium and neurovascular unit mediated) as is the BBB as a therapeutic target including increasing the uptake of systemically delivered therapeutics across the BBB, enhancing clearance of potential neurotoxic compounds via the BBB, and preventing BBB dysfunction. Finally, a need for novel biomarkers of BBB dysfunction is addressed.
- 1 March 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (3) , 661-672
Top Cited PapersBlood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments
Cerebral endothelial cells and their linking tight junctions form a unique, dynamic and multi-functional interface, the blood-brain barrier (BBB). The endothelium is regulated by perivascular cells and components forming the neurovascular unit. This review examines BBB and neurovascular unit changes in normal aging and in neurodegenerative disorders, particularly focusing on Alzheimer disease, cerebral amyloid angiopathy and vascular dementia. Increasing evidence indicates BBB dysfunction contributes to neurodegeneration. Mechanisms underlying BBB dysfunction are outlined (endothelium and neurovascular unit mediated) as is the BBB as a therapeutic target including increasing the uptake of systemically delivered therapeutics across the BBB, enhancing clearance of potential neurotoxic compounds via the BBB, and preventing BBB dysfunction. Finally, a need for novel biomarkers of BBB dysfunction is addressed.